Active ingredientNaftidrofuryl Hydrogen OxalateCat. No. P-N009-001CAS 3200-06-4Family · Pharmaceutical analytical standards
Naftidrofuryl
A vasodilator that blocks serotonin 5-HT2 receptors and improves blood flow; on the market since the late 1960s, it is used for intermittent claudication caused by peripheral arterial disease. This family brings together the active ingredient, pharmacopoeial impurities and other impurities.
Did you know?Its official United States name is nafronyl. Besides blocking 5-HT2 receptors, it is thought to stimulate the Krebs cycle inside cells, boosting production of ATP, their energy currency.
Go to the active ingredient →Active ingredientNaftidrofuryl Hydrogen OxalateCat. No. P-N009-001CAS 3200-06-4
Pharmacopoeial impurity3-(1-Naphthyl)-2-Tetrahydrofurfurylpropionic AcidCat. No. P-N009-002CAS 25379-26-4
Pharmacopoeial impurityNaftidrofuryl EP Impurity BCat. No. P-N009-003CAS 35997-58-1
Pharmacopoeial impurityNaftidrofuryl EP Impurity FCat. No. P-N009-004CAS 41359-72-2
ImpurityNaftidrofuryl Oxalate Impurity CCat. No. P-N009-006CAS 115025-99-5
ImpurityNaftidrofuryl Impurity CCat. No. P-N009-009No product matches your search.
EDQM standards 3
The official European Pharmacopoeia standards for this family.
ImpurityNaftidrofuryl impurity A CRSEDQM code Y0000120Family NaftidrofurylImpurityNaftidrofuryl impurity B CRSEDQM code Y0000121Family NaftidrofurylImpurityNaftidrofuryl impurity F CRSEDQM code Y0000331Family NaftidrofurylNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.